Predicting Ocular Relapse in Sarcoid Uveitis: Macular Edema and Baseline Inflammation as Critical Prognostic Markers

Predicting Ocular Relapse in Sarcoid Uveitis: Macular Edema and Baseline Inflammation as Critical Prognostic Markers

A multicentric study of 336 patients reveals that two-thirds of sarcoid uveitis cases experience relapse, primarily driven by baseline macular edema and persistent inflammation. Despite high recurrence rates, long-term visual prognosis remains favorable for most, with low rates of severe vision loss over nearly eight years.
The Rising Burden of Sarcoidosis in England: New Evidence of Increasing Incidence and Significant Mortality Gaps

The Rising Burden of Sarcoidosis in England: New Evidence of Increasing Incidence and Significant Mortality Gaps

A landmark study of over 18,000 patients reveals that sarcoidosis incidence and prevalence in England are rising, particularly among older adults. With a 36% higher mortality risk compared to the general population, these findings demand a shift in how the healthcare system prioritizes this complex multisystem disease.